Playlist Mode Print Mode Video Only Audio Only Channel A Channel B

News chronological

9 items before 1072687 (Keyword: "side-effects" (~42 currently found))

YOUTUBE (NewsNation) - Ozempic maker sued after woman dies from stomach paralysis

A consumer of Ozempic has allegedly died from stomach paralysis and Jonathan Orent, an attorney representing Martha Ettinghoff's family, tells "Elizabeth Vargas Reports" the risks "could have been warned of." MORE: https://www.newsnationnow.com/vargasreports/ozempic-maker-woman-dies-stomach-paralysis/

YOUTUBE (NewsNation) - Ozempic maker sued after woman dies from stomach paralysis | Elizabeth Vargas Reports

Attorney Jonathan Orent joins NewsNation to discuss the wrongful death lawsuit filed against Novo Nordisk after Marsha Ettinghoff, a consumer of Ozempic, died from stomach paralysis. Anchor Elizabeth Vargas delivers the biggest stories, without bias or opinion. Watch "Elizabeth Vargas Reports" every weeknight at 7p/6C on NewsNation. #VargasReports NewsNation is your source for fact-based, unbiased news for all Americans.

NYTIMES (Dani Blum) - A New Concern About Weight Loss Drugs: What if They Work Too Well?

Some patients in a clinical trial of one new drug lost so much weight that they became concerned and dropped out.

NYTIMES (Rebecca Robbins) - Hims & Hers Withdraws Knockoff Weight-Loss Pill After Regulatory Scrutiny

Federal officials had warned that the new product from the online provider of weight loss drugs might be illegal.

YOUTUBE (NewsNation) - Weight-loss users sue drugmakers, citing adverse effects

As the use of weight loss drugs becomes more popular, over 4,000 users say they’ve experienced serious health effects and filed lawsuits against drugmakers.

NEWSNATIONNOW (Brooke Shafer) - Patients sue GLP-1 drugmakers, alleging severe side effects

Some patients have pointed to severe undisclosed side effects, including blindness, loss of brain function and organ damage.

YOUTUBE (NewsNation) - Patients not adequately warned about GLP-1 drug risks: Attorney | Morning in America

Thousands of patients are suing the companies behind GLP-1 weight loss drugs, alleging they caused blindness, loss of brain function and organ damage. Jonathan Orent, an attorney representing some of the plaintiffs, tells “Morning in America” that European warning labels also include information about the risk of blindness. He argues that drugmakers have failed to sufficiently inform doctors in the U.S. about the full risk-benefit profile, limiting physicians’ ability to discuss those risks with their patients. Start your day with "Morning in America," NewsNation's live three-hour national morning newscast hosted by Markie Martin. Weekdays starting at 6a/5C. #MorningInAmerica NewsNation is your source for fact-based, unbiased news…

YOUTUBE (NewsNation) - Patients sue GLP-1 drugmakers, citing severe side effects | Morning in America

At least 3,000 patients have filed lawsuits against the companies behind GLP-1 weight loss drugs, alleging severe health risks, including blindness. NewsNation's Brooke Shafer has the story on "Morning in America." Start your day with "Morning in America," NewsNation's live three-hour national morning newscast hosted by Markie Martin. Weekdays starting at 6a/5C. #MorningInAmerica NewsNation is your source for fact-based, unbiased news for all Americans.

YOUTUBE (NewsNation) - Dr. Mark Hyman on GLP‑1 drugs facing multiple lawsuits | CUOMO

Dr. Mark Hyman returned to NewsNation to discuss the surge of lawsuits and the future of GLP‑1 drugs. Ozempic, once hailed as a “miracle” weight‑loss medication, helped drive more than 31 million Americans to GLP‑1s despite early warnings he discussed on the show in 2023. Now, thousands of lawsuits allege the drugs caused serious health issues, including eye strokes, brain dysfunction and potentially life‑threatening intestinal problems. Chris Cuomo hosts "CUOMO," a no-nonsense show featuring the day's most important news from all perspectives. "CUOMO" airs weeknights at 8p/7C on NewsNation. #CUOMO NewsNation is your source for fact-based, unbiased news for all Americans.